INA’s Loss in Kimia Farma
Monday, September 8, 2025
INA’s Rp 1.86 trillion investment in Kimia Farma goes bust amid corruption suspicions.
arsip tempo : 177349144635.
DJAGAD Prakasa Dwialam is targeting a drastic slimming down of Kimia Farma’s pharmaceutical portfolio this year, from 578 stock-keeping units (SKU) to just 150. The Chief Executive Officer (CEO) of the state-owned pharmaceutical company wants Kimia Farma’s drugs to be more efficient to produce and easier to distribute to the market.
Djagad is confident that trimming SKUs will have a positive impact on the company’s perfo
Subscribe to continue reading.
We craft news with stories.
For the benefits of subscribing to Digital Tempo, See More











